tiprankstipranks
Trending News
More News >
Huakang Biomedical Holdings Company Limited (HK:8622)
:8622
Hong Kong Market

Huakang Biomedical Holdings Company Limited (8622) Income Statement

Compare
0 Followers

Huakang Biomedical Holdings Company Limited Income Statement

Last quarter (Q4 2024), Huakang Biomedical Holdings Company Limited's total revenue was ¥6.72M, a decrease of -1.96% from the same quarter last year. In Q4, Huakang Biomedical Holdings Company Limited's net income was ¥-1.19M. See Huakang Biomedical Holdings Company Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 25.36M¥ 24.63M¥ 25.33M¥ 26.13M¥ 21.97M
Gross Profit
¥ 17.07M¥ 16.09M¥ 16.91M¥ 16.46M¥ 14.72M
Operating Expenses
¥ 22.08M¥ 16.09M¥ 21.27M¥ 20.24M¥ 22.57M
Depreciation and Amortization
¥ 1.60M¥ 3.18M¥ 3.14M¥ 2.95M¥ 3.19M
EBITDA
¥ -3.41M¥ -2.55M¥ 188.00K¥ -852.00K¥ -8.10M
Operating Income
¥ -5.01M¥ -6.48M¥ -2.95M¥ -3.80M¥ -8.74M
Other Income/Expenses
¥ 853.00K¥ 701.00K¥ 2.08M¥ 675.00K¥ -2.75M
Pretax Income
¥ -4.16M¥ -5.78M¥ -3.01M¥ -3.90M¥ -11.37M
Net Income
¥ -4.16M¥ -5.78M¥ -3.08M¥ -4.22M¥ -11.63M
Per Share Metrics
Basic EPS
¥ -0.01¥ -0.01¥ -0.01¥ -0.01¥ -0.03
Diluted EPS
¥ -0.01¥ -0.01¥ -0.01¥ -0.01¥ -0.03
Weighted Average Shares Outstanding
482.48M 415.97M 404.64M 400.00M 400.00M
Weighted Average Shares Outstanding (Diluted)
482.44M 415.96M 404.64M 400.00M 400.00M
Currency in CNY

Huakang Biomedical Holdings Company Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis